212 related articles for article (PubMed ID: 31165865)
1. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
[TBL] [Abstract][Full Text] [Related]
2. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
[TBL] [Abstract][Full Text] [Related]
3. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.
Ledbetter J; Brannman L; Wade SW; Gonzales T; Kong AM
J Med Econ; 2020 Feb; 23(2):139-147. PubMed ID: 31432723
[No Abstract] [Full Text] [Related]
4. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
Amand C; Tong S; Kieffer A; Kyaw MH
BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.
Palmer L; Hall CB; Katkin JP; Shi N; Masaquel AS; McLaurin KK; Mahadevia PJ
Pediatr Pulmonol; 2010 Aug; 45(8):772-81. PubMed ID: 20632403
[TBL] [Abstract][Full Text] [Related]
8. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
[TBL] [Abstract][Full Text] [Related]
9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Ares-Gómez S; Mallah N; Pardo-Seco J; Malvar-Pintos A; Pérez-Martínez O; Otero-Barrós MT; Súarez-Gaiche N; Santiago-Pérez MI; González-Pérez JM; López-Pérez LR; Rosón B; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F
Pediatr Allergy Immunol; 2024 May; 35(5):e14131. PubMed ID: 38700124
[TBL] [Abstract][Full Text] [Related]
10. Cumulative incidence of post-infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis.
Nguyen-Van-Tam J; Wyffels V; Smulders M; Mazumder D; Tyagi R; Gupta N; Gavart S; Fleischhackl R
Influenza Other Respir Viruses; 2020 Nov; 14(6):730-738. PubMed ID: 32533658
[TBL] [Abstract][Full Text] [Related]
11. Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis.
Lofland JH; O'Connor JP; Chatterton ML; Moxey ED; Paddock LE; Nash DB; Desai SA
Clin Ther; 2000 Nov; 22(11):1357-69. PubMed ID: 11117660
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study.
Carbonell-Estrany X; Pérez-Yarza EG; García LS; Guzmán Cabañas JM; Bòria EV; Atienza BB;
PLoS One; 2015; 10(5):e0125422. PubMed ID: 25955487
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
Dovizio M; Veronesi C; Bartolini F; Cavaliere A; Grego S; Pagliaro R; Procacci C; Ubertazzo L; Bertizzolo L; Muzii B; Parisi S; Perrone V; Baraldi E; Bozzola E; Mosca F; Esposti LD
Ital J Pediatr; 2024 Mar; 50(1):57. PubMed ID: 38528616
[TBL] [Abstract][Full Text] [Related]
14. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants.
Shi N; Palmer L; Chu BC; Katkin JP; Hall CB; Masaquel AS; Mahadevia PJ
J Med Econ; 2011; 14(3):335-40. PubMed ID: 21524154
[TBL] [Abstract][Full Text] [Related]
15. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
Jalink MB; Langley JM; Dodds L; Andreou P
Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017.
Simões EAF; Botteman M; Chirikov V
J Infect Dis; 2024 Apr; 229(4):1112-1122. PubMed ID: 37625899
[TBL] [Abstract][Full Text] [Related]
17. The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study.
Chirikov V; Botteman M; Simões EAF
Clinicoecon Outcomes Res; 2022; 14():699-714. PubMed ID: 36389101
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.
Suh M; Movva N; Jiang X; Reichert H; Bylsma LC; Fryzek JP; Nelson CB
J Infect Dis; 2022 Aug; 226(Suppl 2):S184-S194. PubMed ID: 35968879
[TBL] [Abstract][Full Text] [Related]
19. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of health care resource utilization among preterm and term infants hospitalized with Human Respiratory Syncytial Virus infections: A systematic review and meta-analysis of retrospective cohort studies.
Kenmoe S; Kengne-Nde C; Modiyinji AF; La Rosa G; Njouom R
PLoS One; 2020; 15(2):e0229357. PubMed ID: 32084214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
